Benefits of routine prophylactic femoral access during transvenous lead extraction.


Journal

Heart rhythm
ISSN: 1556-3871
Titre abrégé: Heart Rhythm
Pays: United States
ID NLM: 101200317

Informations de publication

Date de publication:
06 2021
Historique:
received: 01 01 2021
revised: 26 01 2021
accepted: 04 02 2021
pubmed: 13 2 2021
medline: 11 1 2022
entrez: 12 2 2021
Statut: ppublish

Résumé

The number of patients requiring lead extraction has been increasing in recent years. Despite significant advances in operator experience and technique, unexpected complications may occur. Prophylactic placement of femoral sheaths allows for immediate endovascular access for emergency procedures and may shorten response time in the event of complications. The purpose of this study was to assess the benefits of routine prophylactic femoral access in patients undergoing transvenous lead extraction (TLE) and to evaluate the methods, frequency, and efficacy of the emergency measures used in those patients. We conducted a retrospective analysis of patients who underwent TLE from January 2012 to February 2019. The data were analyzed with regard to procedural complications and deployment of emergency measures via femoral access. Two hundred eighty-five patients (mean age 65.3 ± 15.5 years) were included in the study. Median lead dwell time was 84 months (interquartile range 58-144). Overall complication rate was 4.2% (n = 12), with 1.8% major complications (n = 5). Clinical success rate was 97.2%. Procedure-related mortality was 1.1% (n = 3). Femoral sheaths were actively engaged in 9.1% (n = 26) of cases. Deployment of snares was the most common intervention (n = 10), followed by prophylactic (n = 6) or emergency placement (n = 1) of occlusion balloons, temporary pacing (n = 3), venous angioplasty (n = 3), diagnostic venography (n = 3), and extracorporeal membrane oxygenation (n = 1). We did not observe any femoral vascular complications due to prophylactic sheath placement. Routine prophylactic placement of femoral sheaths shortens response time and quickly establishes control in the event of various complications that may occur during TLE procedures.

Sections du résumé

BACKGROUND
The number of patients requiring lead extraction has been increasing in recent years. Despite significant advances in operator experience and technique, unexpected complications may occur. Prophylactic placement of femoral sheaths allows for immediate endovascular access for emergency procedures and may shorten response time in the event of complications.
OBJECTIVE
The purpose of this study was to assess the benefits of routine prophylactic femoral access in patients undergoing transvenous lead extraction (TLE) and to evaluate the methods, frequency, and efficacy of the emergency measures used in those patients.
METHODS
We conducted a retrospective analysis of patients who underwent TLE from January 2012 to February 2019. The data were analyzed with regard to procedural complications and deployment of emergency measures via femoral access.
RESULTS
Two hundred eighty-five patients (mean age 65.3 ± 15.5 years) were included in the study. Median lead dwell time was 84 months (interquartile range 58-144). Overall complication rate was 4.2% (n = 12), with 1.8% major complications (n = 5). Clinical success rate was 97.2%. Procedure-related mortality was 1.1% (n = 3). Femoral sheaths were actively engaged in 9.1% (n = 26) of cases. Deployment of snares was the most common intervention (n = 10), followed by prophylactic (n = 6) or emergency placement (n = 1) of occlusion balloons, temporary pacing (n = 3), venous angioplasty (n = 3), diagnostic venography (n = 3), and extracorporeal membrane oxygenation (n = 1). We did not observe any femoral vascular complications due to prophylactic sheath placement.
CONCLUSION
Routine prophylactic placement of femoral sheaths shortens response time and quickly establishes control in the event of various complications that may occur during TLE procedures.

Identifiants

pubmed: 33577972
pii: S1547-5271(21)00112-0
doi: 10.1016/j.hrthm.2021.02.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

970-976

Informations de copyright

Copyright © 2021 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Auteurs

Da-Un Chung (DU)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Lisa Müller (L)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Timm Ubben (T)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Yalin Yildirim (Y)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Johannes Petersen (J)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Christoph Sinning (C)

Department of Cardiology, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Liesa Castro (L)

Department of Cardiology, Angiology & Critical Care Medicine, University Hospital Lübeck, Germany.

Till Joscha Demal (TJ)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Lukas Kaiser (L)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Nils Gosau (N)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Hermann Reichenspurner (H)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany.

Stephan Willems (S)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Simon Pecha (S)

Department of Cardiac Surgery, University Heart & Vascular Center Hamburg, University Hospital Eppendorf, Hamburg, Germany. Electronic address: s.pecha@uke.de.

Samer Hakmi (S)

Department of Cardiology & Critical Care Medicine, Asklepios Klinik St. Georg, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH